de Dios, Rubén https://orcid.org/0000-0001-6704-9149
Gadar, Kavita https://orcid.org/0000-0002-7907-1076
Proctor, Chris R
Maslova, Evgenia
Han, Jie https://orcid.org/0000-0002-7777-0455
Soliman, Mohamed A N https://orcid.org/0000-0002-6392-6631
Krawiel, Dominika
Dunbar, Emma L
Singh, Bhupender
Peros, Stelinda
Killelea, Tom
Warnke, Anna-Luisa https://orcid.org/0009-0006-0621-7878
Haugland, Marius M
Bolt, Edward L
Lentz, Christian S
Rudolph, Christian J https://orcid.org/0000-0003-2493-3748
McCarthy, Ronan R https://orcid.org/0000-0002-7480-6352
Funding for this research was provided by:
National Centre for the Replacement Refinement and Reduction of Animals in Research (NC/V001582/1)
UKRI | Biotechnology and Biological Sciences Research Council (BB/V007823/1)
UKRI | Biotechnology and Biological Sciences Research Council (BB/T007168/1)
UKRI | Biotechnology and Biological Sciences Research Council (BB/T006625-1)
UKRI | Biotechnology and Biological Sciences Research Council (BB/W000393/1)
Academy of Medical Sciences (SBF006\1040)
UKRI | Medical Research Council (MR/Y001354/1)
North Norwegian Health Trust (HN 1688-23)
YERUN
Tromsø Research Foundation
Article History
Received: 15 January 2025
Revised: 4 March 2025
Accepted: 6 March 2025
First Online: 1 April 2025
Disclosure and competing interests statement
: Brunel University London holds patents and PCTs covering the therapeutic use of artificial sweeteners and their use as antibiotic potentiators.